Chemours Rises as UBS Upgrades Stock To 'Buy'

The Chemours Co. (CC) shares gained successful intraday trading Tuesday pursuing an upgrade from UBS analysts, who said investors person been excessively antagonistic connected nan chemic maker's stock.

Shares of Chemours roseate astir 2% to $22.75 arsenic of 2 p.m. ET Tuesday aft UBS raised its standing connected nan institution to "buy" from "neutral," and accrued its value target to $30 from $28.

UBS Sees Improving TiO2 Earnings, Refrigerants Demand

The analysts said they spot imaginable for nan banal to outperform amid "a much normal level of earnings" for colorant titanium dioxide (TiO2) and “favorable demand/price drivers successful refrigerants into 2025.”

The analysts based on that Chemours’ TiO2 volumes person been down successful portion because of one-time issues this year, and they expect them to drawback up to competitors complete nan adjacent year. Because of that, they spot TiO2 profits “to amended sequentially done this year.”

The analysts added that regulatory efforts to conflict world warming will thrust request for lower-emitting coolants, which "should disproportionally benefit” Chemours’ next-generation hydrofluoroolefins (HFO) refrigerants. 

Even pinch today’s gains, Chemours shares person still mislaid much than a 4th of their worth successful 2024.